Vimarsana
Biggest News Aggregation in the World

Page 7 - Juncker Plan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Juncker Plan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Juncker Plan Today - Breaking & Trending Today

EIB Group financed €211m loans, guarantees and equity in Slovakia in 2020 - Vimarsana News

EIB Group financed €211m loans, guarantees and equity in Slovakia in 2020

The EIB signed new loans amounting to €148 million and the EIF committed around €63 million in four equity and guarantee operations, benefiting a total of 2 600 businesses and supporting 25 000 jobs.

Median Technologies: Median Strengthens its iBiopsy Leadership Team With the Appointment of Thomas Bonnefont as Chief Operating and Commercial Officer and the Appointment of Mike Doherty as Sr. Strategy Advisor, Product Development - Vimarsana News

Median Technologies: Median Strengthens its iBiopsy Leadership Team With the Appointment of Thomas Bonnefont as Chief Operating and Commercial Officer and the Appointment of Mike Doherty as Sr. Strategy Advisor, Product Development

(2) These two appointments follow a series of first successful achievements for iBiopsy in 2020 and early 2021. Median prepares to launch its iBiopsy product development plan, including regulatory aspects, define its go-to-market strategy then expand its iBiopsy operations globally. Regulatory News: Thomas Bonnefont (Photo: Median Technologies) Median Technologies (ALMDT:PA) (Paris:ALMDT) announced today the appointment of Thomas Bonnefont to the newly created position of Chief Operating and Commercial Officer of the iBiopsy Business Unit as well as the appointment of Mike Doherty as Sr. Stra...

iBiopsy: Median Technologies Continues Its Strong Positioning in Early-Stage Diagnosis with a New iBiopsy Clinical Development Plan on Lung Cancer Screening (LCS) - Vimarsana News

iBiopsy: Median Technologies Continues Its Strong Positioning in Early-Stage Diagnosis with a New iBiopsy Clinical Development Plan on Lung Cancer Screening (LCS)

(1) Median is building a cloud based end-to-end approach performing both localization and discrimination of malignant and benign lung lesions. The company plans to demonstrate the potential of deep learning models to increase the accuracy, consistency and adoption of lung cancer screening worldwide. First results for a proof of concept on a cohort of 1,800 patients are expected in H2, 2021. Regulatory News: Median Technologies (ALMDT:PA) (Paris:ALMDT) unveils today a new iBiopsy Clinical Development Plan (CDP) for the diagnosis of early-stage lung cancer in high-risk populations based on Low ...

Europe: France: EIB provides €50 million to support Forsee Power's growth - Vimarsana News

Europe: France: EIB provides €50 million to support Forsee Power's growth

©Shutterstock The EIB is providing €50 million to Forsee Power to help create a European battery champion. This second loan – following an initial €20 million granted in late 2017 under the Juncker Plan – will finance the expansion of the company’s range of products for 100% battery-powered, hydrogen hybrid and thermal hybrid vehicles. It will facilitate product development for new markets and strengthen Forsee Power’s manufacturing capacity. Forsee Power – the smart battery systems for the electromobility markets expert – has announced the conclusion of €105 million in ...

EIB Group activity in Portugal: highest lending volumes since 2014 - Vimarsana News

EIB Group activity in Portugal: highest lending volumes since 2014

EIB Group activity in Portugal: highest lending volumes since 2014